43. A pharmaceutical company is conducting a Phase II clinical trial for a new antidepressant. What medicinal aspect is primarily assessed in this phase?
A.
Long-term safety and effectiveness in a large population.
B.
Preliminary efficacy, dosage range, and short-term side effects in a small number of patients with the target condition.
✓
C.
Safety in healthy volunteers.
D.
Post-marketing surveillance.
📖 Additional Information
Long-term safety and effectiveness in a large population.
Preliminary efficacy, dosage range, and short-term side effects in a small number of patients with the target condition.
